TMCnet News

Global Spine Biologics Market to Grow 2% by 2020 - Emerging MI Sacroiliac Joint Fusion Technique - Research and Markets
[July 04, 2016]

Global Spine Biologics Market to Grow 2% by 2020 - Emerging MI Sacroiliac Joint Fusion Technique - Research and Markets


Research and Markets has announced the addition of the "Global Spine Biologics Market 2016-2020" report to their offering.

The report forecasts the global spine biologics market to grow at a CAGR of 2.07% during the period 2016-2020. To calculate the market size, we consider the revenue generated from the sales of the following:

  • Allograft
  • Stem cells
  • Bone morphogenetic proteins (BMPs)
  • Demineralized bone matrix (DBM)
  • Synthetic bone grafts

According to the report, a key growth driver is the rising popularity of MI spinal and robot-assisted surgeries. The shift in preference to MI surgeries from open surgical method has led to the high adoption of spine biologics in MI spine surgeries. Traditional open surgeries can cause various post-operation complications such as pain, partially collapsed lungs, blood clots, fatigue, muscle atrophy, and infections.

Many medical facilities are conducting spinal fusion surgeries to repair the vertebrae and treat other spine disases. Spine fusion surgery is performed to treat severe degeneration of the disc material in the spine by placing a bone graft, resulting in generation of a new bone that bridges the vertebrae.



Further, the report states that one challenge that could restrict market growth is complication associated with spinal surgeries. Sometimes the bones take longer to fuse (delayed union) and in some cases the bones do not fuse (non-union). This requires the need for a second surgery to allow healing of the bones.

Key vendors:


  • Medtronic
  • Johnson & Johnson
  • Stryker
  • NuVasive
  • Zimmer Biomet
  • SeaSpine

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Spine biologics: An overview

PART 06: Market landscape

PART 07: Market segmentation by product

PART 08: Global spine biologics market by allograft

PART 09: Global spine biologics market by stem cells

PART 10: Global spine biologics market by BMP

PART 11: Global spine biologics market by DBM

PART 12: Global spine biologics market by synthetic bone grafts

PART 13: Geographical segmentation

PART 14: Key leading countries

PART 15: Market drivers

PART 16: Impact of drivers

PART 17: Market challenges

PART 18: Impact of drivers and challenges

PART 19: Market trends

PART 20: Vendor landscape

PART 21: Appendix

For more information visit http://www.researchandmarkets.com/research/2v64jp/global_spine


[ Back To TMCnet.com's Homepage ]